Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4051
PUT
Insulet
PODD
$11.5B
| $1.55M | ﹤0.01% |
50,000
-50,000
| -50% | -$1.47M |
|
|
FNGN
4052
DELISTED
Financial Engines, Inc.
FNGN
| $1.55M | ﹤0.01% |
36,416
-572
| -2% | -$24.3K |
|
|
LXK
4053
PUT
DELISTED
Lexmark Intl Inc
LXK
| $1.55M | ﹤0.01% |
35,000
-16,000
| -31% | -$711K |
|
4054
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.76B
| $1.55M | ﹤0.01% |
53,860
| – | – |
|
4055
ProShares UltraPro Short QQQ
SQQQ
$2.04B
| $1.54M | ﹤0.01% |
+6
| New | +$1.45M |
|
4056
PUT
Enbridge
ENB
$119B
| $1.54M | ﹤0.01% |
+33,000
| New | +$1.64M |
|
4057
PUT
Marvell Technology
MRVL
$168B
| $1.54M | ﹤0.01% |
117,000
+26,600
| +29% | +$382K |
|
4058
CALL
Motorola Solutions
MSI
$72.3B
| $1.54M | ﹤0.01% |
26,900
-129,400
| -83% | -$7.75M |
|
4059
TriMas Corp
TRS
$1.43B
| $1.54M | ﹤0.01% |
65,383
+14,174
| +28% | +$338K |
|
|
ALX
4060
Alexander's
ALX
$1.3B
| $1.54M | ﹤0.01% |
3,759
+830
| +28% | +$353K |
|
|
CCC
4061
DELISTED
Calgon Carbon Corp
CCC
| $1.54M | ﹤0.01% |
79,529
+14,151
| +22% | +$303K |
|
|
BGFV
4062
DELISTED
Big 5 Sporting Goods
BGFV
| $1.54M | ﹤0.01% |
108,395
+15,715
| +17% | +$218K |
|
|
JOYY
4063
JOYY Inc
JOYY
$3.71B
| $1.54M | ﹤0.01% |
22,158
-4,457
| -17% | -$297K |
|
4064
PUT
Exelixis
EXEL
$13.3B
| $1.54M | ﹤0.01% |
409,400
+309,400
| +309% | +$1.01M |
|
4065
CALL
ProShares UltraShort QQQ
QID
$282M
| $1.54M | ﹤0.01% |
547
-305
| -36% | -$843K |
|
|
SYNH
4066
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $1.54M | ﹤0.01% |
38,308
+15,091
| +65% | +$521K |
|
|
LGCY
4067
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
| $1.54M | ﹤0.01% |
179,182
-56,169
| -24% | -$619K |
|
4068
CALL
State Street
STT
$50.6B
| $1.53M | ﹤0.01% |
19,900
+2,000
| +11% | +$156K |
|
4069
PUT
Affiliated Managers Group
AMG
$9.69B
| $1.53M | ﹤0.01% |
7,000
+3,400
| +94% | +$756K |
|
|
4070
Insulet
PODD
$11.5B
| $1.53M | ﹤0.01% |
49,377
-109,802
| -69% | -$3.24M |
|
|
PX
4071
PUT
DELISTED
Praxair Inc
PX
| $1.53M | ﹤0.01% |
12,800
+3,900
| +44% | +$475K |
|
4072
Invesco S&P SmallCap 600 Pure Growth ETF
RZG
$142M
| $1.53M | ﹤0.01% |
50,946
-3,660
| -7% | -$109K |
|
4073
Vanguard Health Care ETF
VHT
$18.1B
| $1.52M | ﹤0.01% |
10,896
-8,513
| -44% | -$1.18M |
|
|
DSCI
4074
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $1.52M | ﹤0.01% |
212,947
+195,902
| +1,149% | +$1.47M |
|
|
FNSR
4075
DELISTED
Finisar Corp
FNSR
| $1.52M | ﹤0.01% |
85,279
+16,684
| +24% | +$354K |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.